Stratos Wealth Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$499K	Buy	98,704 +86,730	+724%	+$439K	0.01%	927
2025 Q1	$63.3K	Sell	11,974 -4,579	-28%	-$24.2K	﹤0.01%	1333
2024 Q4	$112K	Buy	+16,553	New	+$112K	﹤0.01%	1395
2024 Q2	–	Sell	-13,436	Closed	-$134K	–	1437
2024 Q1	$134K	Buy	+13,436	New	+$134K	﹤0.01%	1324